Automating regulatory submissions for life sciences
We’re building AI agents that speed up drug trials by automating the manual consolidation and document prep required for every IND submission. Today, biotechs spend months stitching together reports from contractors and internal teams just to file and get to their first-in-human trial.
What they do:
AI infrastructure for biosecurity
Quick facts:
HQ: New York, NY, United States
What they do:
Regulating the immune system to block cancer & autoimmune diseases
Quick facts:
HQ: Philadelphia, PA, United States
What they do:
Biospecimen logistics & operations layer to accelerate drug dev
Quick facts:
HQ: Boulder, CO, United States
What they do:
Foundation models and autonomous chambers for plant biology
Quick facts:
What they do:
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
Quick facts:
HQ: Oxford, United Kingdom
What they do:
People infrastructure for the future of work
Quick facts:
HQ: San Francisco, CA, United States
Automating regulatory submissions for life sciences
San Francisco, CA, United States
2 employees, according to the company profile.
There are no funding rounds for Scoop in our data.
Similar startups: TwentyTwo, SFA Therapeutics, and Paceline Bio.